CCR4 and hematoma: Recombinant C-C chemokine ligand17 (CCL17) promotes hematoma clearance and improves nerve injury by activating the C-C chemokine receptor 4 (CCR4)/extracellular regulated protein kinase (ERK)/Nrf2 signaling pathway to increase CD163 expression (51).